NASDAQ:EVOK Evoke Pharma (EVOK) Stock Price, News & Analysis → My next big prediction isn’t a prediction (From Porter & Company) (Ad) Free EVOK Stock Alerts $0.62 0.00 (0.00%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$0.59▼$0.6350-Day Range$0.62▼$0.9452-Week Range$0.56▼$3.15Volume61,129 shsAverage Volume69,057 shsMarket Capitalization$2.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Evoke Pharma alerts: Email Address Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency About Evoke Pharma Stock (NASDAQ:EVOK)Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.Read More EVOK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVOK Stock News HeadlinesMarch 18, 2024 | msn.comBig change is the only constant in eco: India IncMarch 17, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)March 18, 2024 | Monument Traders Alliance (Ad)Make This $3 Trade the Instant the Opening Bell RingsSince the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…March 17, 2024 | seekingalpha.comEvoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | finance.yahoo.comEvoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?March 15, 2024 | msn.comBrain gain: Hope rises with new dementia treatmentsMarch 15, 2024 | finance.yahoo.comEvoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finanznachrichten.deEvoke Pharma, Inc.: Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 18, 2024 | Paradigm Press (Ad)8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: March 15, 2024 | msn.comEVOK Stock Earnings: Evoke Pharma Misses EPS, Beats Revenue for Q4 2023March 14, 2024 | msn.com‘Would have torn Modi into pieces’: DMK minister TM Anbarasan booked for remarks against PMMarch 14, 2024 | globenewswire.comEvoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 13, 2024 | benzinga.comA Preview Of Evoke Pharma's EarningsMarch 13, 2024 | markets.businessinsider.comEvoke Pharma Inc Registered Shs hosts conference call for investorsMarch 12, 2024 | americanbankingnews.comEvoke Pharma (EVOK) to Release Earnings on ThursdayMarch 9, 2024 | americanbankingnews.comEvoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.comMarch 7, 2024 | globenewswire.comEvoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024February 27, 2024 | investing.comEvoke Pharma Inc (EVOK)February 26, 2024 | msn.comConfronting the legacy of the Holocaust in 2024 film ‘Treasure’ - reviewFebruary 26, 2024 | finance.yahoo.comEVOKE PHARMA INC.DL-,0001 (EV00.DU)February 24, 2024 | benzinga.comEvoke Pharma Stock (NASDAQ:EVOK) Dividends: History, Yield and DatesFebruary 22, 2024 | finance.yahoo.comLift Off with Spring Sculpture Exhibitions at Frederik Meijer Gardens & Sculpture ParkFebruary 15, 2024 | money.usnews.comEvoke Pharma IncFebruary 14, 2024 | finance.yahoo.comEvoke Pharma Announces Closing of $7.5 Million Public OfferingFebruary 14, 2024 | globenewswire.comEvoke Pharma Announces Closing of $7.5 Million Public OfferingFebruary 10, 2024 | markets.businessinsider.comEvoke Pharma Announces Pricing of Recent OfferingFebruary 10, 2024 | msn.comEvoke Pharma Strikes Deal to Offer Stocks and WarrantsSee More Headlines Receive EVOK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today3/18/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:EVOK CUSIPN/A CIK1403708 Webwww.evokepharma.com Phone(858) 345-1494FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,220,000.00 Net Margins-150.43% Pretax Margin-176.93% Return on Equity-1,305.92% Return on Assets-86.99% Debt Debt-to-Equity Ratio9.29 Current Ratio3.50 Quick Ratio3.27 Sales & Book Value Annual Sales$5.18 million Price / Sales0.40 Cash FlowN/A Price / Cash FlowN/A Book Value$1.22 per share Price / Book0.51Miscellaneous Outstanding Shares3,340,000Free Float2,949,000Market Cap$2.07 million OptionableNot Optionable Beta0.21 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. David A. Gonyer R.Ph. (Age 60)Co-Founder, CEO & Director Comp: $666.31kMr. Matthew J. D'Onofrio MBA (Age 54)Co-Founder, President, COO, Secretary & Treasurer Comp: $498.12kDr. Marilyn R. Carlson D.M.D. (Age 76)M.D., RAC., Chief Medical Officer Comp: $444.99kMr. Christopher QuesenberryChief Commercial Officer - Gimoti (TM)Key CompetitorsAgile TherapeuticsNASDAQ:AGRXSonoma PharmaceuticalsNASDAQ:SNOACohBarNASDAQ:CWBRQualigen TherapeuticsNASDAQ:QLGNCyclacel PharmaceuticalsNASDAQ:CYCCView All Competitors EVOK Stock Analysis - Frequently Asked Questions How have EVOK shares performed in 2024? Evoke Pharma's stock was trading at $1.0503 at the beginning of the year. Since then, EVOK shares have decreased by 41.0% and is now trading at $0.62. View the best growth stocks for 2024 here. When is Evoke Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our EVOK earnings forecast. How were Evoke Pharma's earnings last quarter? Evoke Pharma, Inc. (NASDAQ:EVOK) issued its quarterly earnings results on Thursday, March, 14th. The specialty pharmaceutical company reported ($0.59) EPS for the quarter. The specialty pharmaceutical company had revenue of $1.68 million for the quarter. Evoke Pharma had a negative trailing twelve-month return on equity of 1,305.92% and a negative net margin of 150.43%. When did Evoke Pharma's stock split? Evoke Pharma's stock reverse split on the morning of Monday, May 23rd 2022. The 1-12 reverse split was announced on Monday, May 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What guidance has Evoke Pharma issued on next quarter's earnings? Evoke Pharma issued an update on its FY 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $14.0 million-$14.0 million, compared to the consensus revenue estimate of $14.0 million. What other stocks do shareholders of Evoke Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evoke Pharma investors own include Bank of Hawaii (BOH), InterDigital (IDCC), STAG Industrial (STAG), Advanced Micro Devices (AMD), Novavax (NVAX), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Pfizer (PFE), Gilead Sciences (GILD) and Bed Bath & Beyond (BBBY). Who are Evoke Pharma's major shareholders? Evoke Pharma's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Evoke Pharma? Shares of EVOK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:EVOK) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetryDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.